Katja Goričar conducted a prognostic analysis on osteosarcoma patients undergoing HD-MTX therapy and discovered that SLCO1B1 (1865+4846T>C) C allele was associated with a higher event-free survival (16). Here, SLCO1B1 is linked to osteosarcoma.